AdaptHealth Corp. $AHCO Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC lowered its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 87.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 9,739 shares of the company’s stock after selling 68,402 shares during the period. SG Americas Securities LLC’s holdings in AdaptHealth were worth $116,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Rockefeller Capital Management L.P. grew its stake in AdaptHealth by 433.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after purchasing an additional 2,100 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in shares of AdaptHealth in the 3rd quarter worth approximately $35,000. PNC Financial Services Group Inc. increased its holdings in shares of AdaptHealth by 22.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC acquired a new stake in shares of AdaptHealth during the 2nd quarter valued at approximately $96,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Insider Buying and Selling at AdaptHealth

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider directly owned 136,538 shares in the company, valued at approximately $1,373,572.28. The trade was a 7.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AHCO has been the subject of a number of research reports. UBS Group decreased their price objective on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. Wall Street Zen upgraded AdaptHealth from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Robert W. Baird lowered their price target on AdaptHealth from $18.00 to $15.00 and set an “outperform” rating on the stock in a report on Monday, July 6th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a research report on Monday, April 20th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.86.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $10.29 on Tuesday. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. The company has a 50-day moving average of $10.32 and a 200-day moving average of $10.61. AdaptHealth Corp. has a twelve month low of $8.51 and a twelve month high of $13.43. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of -16.60, a price-to-earnings-growth ratio of 0.52 and a beta of 1.45.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.